PLK1 and cancer: Intraperitoneal injection of kRASG12D siRNA loaded EVs resulted in regression of not only the primary pancreatic tumor, but also the metastatic tumors.224 Loaded EVs delivering siRNA against Rad51 (ref. 225) and PLK1 (ref. 226) to cancer cells in vitro reversed cancer phenotypes.